Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
Chinese Patent Office
Argus Health
Boehringer Ingelheim
Chubb
Cantor Fitzgerald
McKesson
Johnson and Johnson

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073618

« Back to Dashboard

NDA 073618 describes CARBIDOPA AND LEVODOPA, which is a drug marketed by Accord Hlthcare, Apotex, Impax Labs, Kv Pharm, Mylan, Sun Pharm Inds, Sun Pharma Global, Actavis Elizabeth, Ani Pharms Inc, Apotex Inc, Mayne Pharma, SCS, and Watson Labs, and is included in twenty-one NDAs. It is available from twenty-six suppliers. Additional details are available on the CARBIDOPA AND LEVODOPA profile page.

The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for 073618
Tradename:CARBIDOPA AND LEVODOPA
Applicant:Mayne Pharma
Ingredient:carbidopa; levodopa
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 073618
Ingredient-typeAmino Acids, Aromatic
Mechanism of ActionDOPA Decarboxylase Inhibitors
Suppliers and Packaging for NDA: 073618
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073618 ANDA Teva Pharmaceuticals USA, Inc. 0093-0292 N 0093-0292-01
CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073618 ANDA Teva Pharmaceuticals USA, Inc. 0093-0292 N 0093-0292-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG;100MG
Approval Date:Aug 28, 1992TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Harvard Business School
Citi
Moodys
Dow
Daiichi Sankyo
Mallinckrodt
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.